51. Review of strategies and factors to maximize cost-effectiveness of robotic hysterectomies and myomectomies in benign gynecological disease
- Author
-
CZ Wu, Gaby N. Moawad, Paul Tyan, and Jordan S. Klebanoff
- Subjects
Laparoscopic surgery ,medicine.medical_specialty ,Gynecological disease ,Cost effectiveness ,Cost-Benefit Analysis ,medicine.medical_treatment ,Blood Loss, Surgical ,030232 urology & nephrology ,Health Informatics ,Hysterectomy ,03 medical and health sciences ,0302 clinical medicine ,Robotic Surgical Procedures ,Blood loss ,Cost Savings ,Laparotomy ,Uterine Myomectomy ,Humans ,Medicine ,Robotic surgery ,business.industry ,General surgery ,technology, industry, and agriculture ,Length of Stay ,body regions ,030220 oncology & carcinogenesis ,Initial cost ,Female ,Laparoscopy ,Surgery ,business ,Genital Diseases, Female ,human activities - Abstract
Common benign gynecologic procedures include hysterectomies and myomectomies, with hysterectomy being the most common gynecologic procedure in the United States [1]. While historically performed via laparotomy, the field of gynecologic surgery was revolutionized with the advent of laparoscopic techniques, with the most recent advancement being the introduction of robotic-assisted surgery in 2005. Robotic surgery has all the benefits of laparoscopic surgery such as decreased blood loss, quicker return to activities, and shorter length of hospital stay. Additional robotic-specific advantages include but are not limited to improved ergonomics, 3D visualization, and intuitive surgical movements. Despite these advantages, one of the most commonly cited drawbacks of robotic surgery is the associated cost. While the initial cost to purchase the robotic console and its associated maintenance costs are relatively high, robotic surgery can be cost-effective when utilized correctly.This article reviews application strategies and factors that can offset traditional costs and maximize the benefits of robotic surgery.
- Published
- 2019